Foresite Labs News Today

Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize…

AI's use in drug discovery and health care is a rare area where the public is also more optimistic than anxious about AI's potential.

Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.

Plus: Electronic health record company Veradigm’s $140 million AI gamble on startup ScienceIO.

– STRIDE Phase 2 primary endpoint of PASI 75 and key secondary endpoints met at all clinically relevant doses tested; sustained maximal target inhibition safely achieved at top dose –

Alumis today announced the presentation of positive clinical data from a Phase 2 clinical trial of ESK-001 at AAD 2024....

Mass Eye and Ear physician-researchers show that retinal imaging can help predict a person’s risk of developing ocular, neuropsychiatric, cardiac, metabolic, and pulmonary diseases. The team also identified genetic loci associated with retinal thinning, which could help develop personalized treat

<p>In a new study, researchers combined OCT retinal imaging, genetics and big data to estimate how likely a person is to develop eye and systemic diseases in the future. They found significant associations between the thinning of different retinal layers and increased risk of developing eye, neuropsychiatric, cardiac, metabolic, and pulmonary diseases and identified genes that are associated with retinal layer thickness. Their hope is one day patients can be provided more personalized risk...

Persons with scoliosis in an adult UK Biobank cohort showed a 45% increased lifetime risk for major adverse cardiac events, the risk driven by two specific heart disorders.

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Oct. 17, 2022.